Adjuvant Temozolomide Beyond Six Cycles in Patients With Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neuro-oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase II Randomized, Multicenter, Open-Label Trial of Continuing Adjuvant Temozolomide Beyond 6 Cycles in Patients With Glioblastoma (GEINO 14-01)
Neuro-oncology 2020 Dec 18;22(12)1851-1861, C Balana, MA Vaz, J Manuel Sepúlveda, C Mesia, S Del Barco, E Pineda, J Muñoz-Langa, A Estival, R de Las Peñas, J Fuster, R Gironés, LM Navarro, M Gil-Gil, M Alonso, A Herrero, S Peralta, C Olier, P Perez-Segura, M Covela, M Martinez-García, A Berrocal, O Gallego, R Luque, FJ Perez-Martín, A Esteve, N Munne, M Domenech, S Villa, C Sanz, C CarratoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.